Skip to content
SPACListing
Browse
ScreenerFilingsMarketDeadlinesSponsorsBanksSectorsLearnPricingWatchlist
Searching

Stem Sales, Inc.

CIK 0001614083

Cash in trust

Not yet disclosed

Trust per share

Redemption value

IPO

Combination deadline

Not disclosed

Filings on record

36

Latest Nov 9, 2017

Overview

Stem Sales, Inc. is a special purpose acquisition company incorporated in Florida and registered with the SEC under CIK 0001614083. The vehicle is sponsored by Stem Sales. IPO closed, trust funded, no definitive agreement announced.

Scores

Recomputed 6m ago

Three readings of Stem Sales, Inc., each an unweighted mean of the components shown beneath it, and each component a percentile against every live SPAC rather than an absolute we invented. They describe the setup, not the merit. How they are built

FOMO

Low

How much attention is this vehicle attracting right now?

0/100

  • Filing activity0

    0 in 30 days

  • News coverage0

    0 stories in 30 days

Attention is not quality. FOMO rises on news volume and on the market paying above trust, both of which have preceded plenty of disappointments.

These are derived measures, not ratings of investment merit. They carry no view on the target, no price target and no recommendation, and a high score is not a reason to buy anything.

SEC filing history

Free tier: filings older than 24 hours
  • 10-Q

    Quarterly report

    Accession 0001173375-17-000071

    Nov 9, 2017

    8y ago

    Open filing
  • 10-Q

    Quarterly report

    Accession 0001173375-17-000058

    Aug 2, 2017

    9y ago

    Open filing
  • 424B3

    Prospectus supplement

    Accession 0001173375-17-000047

    May 24, 2017

    9y ago

    Open filing
  • 10-Q

    Quarterly report

    Accession 0001173375-17-000037

    May 11, 2017

    9y ago

    Open filing
  • 10-K

    Annual report

    Accession 0001173375-17-000016

    Feb 15, 2017

    9y ago

    Open filing
  • 424B3

    Prospectus supplement

    Accession 0001173375-17-000006

    Jan 17, 2017

    9y ago

    Open filing
  • 8-K

    Other events

    Item 8.01 · Accession 0001173375-16-000315

    Dec 27, 2016

    9y ago

    Open filing
  • 8-K

    Other events

    Item 8.01 · Accession 0001173375-16-000309

    Dec 13, 2016

    9y ago

    Open filing
  • 10-Q

    Quarterly report

    Accession 0001173375-16-000278

    Nov 4, 2016

    9y ago

    Open filing
  • 10-Q

    Quarterly report

    Accession 0001173375-16-000252

    Aug 11, 2016

    10y ago

    Open filing
  • 424B3

    Prospectus supplement

    Accession 0001173375-16-000250

    Aug 9, 2016

    10y ago

    Open filing
  • 10-Q/A

    10-Q/A filing

    Accession 0001173375-16-000202

    May 10, 2016

    10y ago

    Open filing
  • 10-Q

    Quarterly report

    Accession 0001173375-16-000199

    May 10, 2016

    10y ago

    Open filing
  • 10-K

    Annual report

    Accession 0001173375-16-000154

    Feb 16, 2016

    10y ago

    Open filing
  • 10-Q

    Quarterly report

    Accession 0001173375-15-000118

    Oct 28, 2015

    11y ago

    Open filing
  • 10-Q

    Quarterly report

    Accession 0001173375-15-000084

    Aug 4, 2015

    11y ago

    Open filing
  • 8-K

    Current report

    Items 4.01, 9.01 · Accession 0001173375-15-000074

    Jun 30, 2015

    11y ago

    Open filing
  • 10-Q

    Quarterly report

    Accession 0001173375-15-000060

    May 12, 2015

    11y ago

    Open filing
  • 10-K

    Annual report

    Accession 0001173375-15-000043

    Apr 6, 2015

    11y ago

    Open filing
  • EFFECT

    Notice of effectiveness

    Accession 9999999995-15-000272

    Feb 3, 2015

    11y ago

    Open filing
  • CORRESP

    Correspondence with SEC staff

    Accession 0001614083-15-000005

    Jan 29, 2015

    11y ago

    Open filing
  • S-1/A

    Amended IPO registration statement

    Accession 0001173375-15-000016

    Jan 26, 2015

    11y ago

    Open filing
  • S-1/A

    Amended IPO registration statement

    Accession 0001614083-15-000003

    Jan 20, 2015

    11y ago

    Open filing
  • UPLOAD

    SEC staff comment letter

    Accession 0000000000-15-002040

    Jan 15, 2015

    11y ago

    Open filing
  • S-1/A

    Amended IPO registration statement

    Accession 0001173375-15-000002

    Jan 5, 2015

    11y ago

    Open filing
  • UPLOAD

    SEC staff comment letter

    Accession 0000000000-14-065602

    Dec 18, 2014

    11y ago

    Open filing
  • S-1/A

    Amended IPO registration statement

    Accession 0001173375-14-000311

    Dec 8, 2014

    11y ago

    Open filing
  • UPLOAD

    SEC staff comment letter

    Accession 0000000000-14-055997

    Nov 10, 2014

    11y ago

    Open filing
  • S-1/A

    Amended IPO registration statement

    Accession 0001173375-14-000270

    Oct 20, 2014

    12y ago

    Open filing
  • UPLOAD

    SEC staff comment letter

    Accession 0000000000-14-051261

    Oct 14, 2014

    12y ago

    Open filing

Stem Sales, Inc.: questions answered

What is Stem Sales, Inc.?

Stem Sales, Inc. is a special purpose acquisition company incorporated in Florida and registered with the SEC under CIK 0001614083. The vehicle is sponsored by Stem Sales. IPO closed, trust funded, no definitive agreement announced.

How much does Stem Sales, Inc. hold in trust?

No trust balance has been disclosed in a filing we have indexed for Stem Sales, Inc.. For a newly priced IPO this is normal: the figure first appears in the quarterly report after closing.

When must Stem Sales, Inc. complete a merger?

No combination deadline appears in the filings we have indexed. The date is stated in the charter and repeated in each quarterly report; where our parser could not establish it with confidence we leave it blank rather than infer one.

What happens if Stem Sales, Inc. does not find a target in time?

The charter requires the vehicle to redeem 100% of the public shares and return the trust, pro rata, to public shareholders. That is the mechanism working as designed rather than a default. Founder shares and warrants are worthless in that outcome, which is why the sponsor's incentive is to get a deal done or to buy more time. Across the market, deadline lapsed without a deal; trust returned to public shareholders.

Can I redeem shares in Stem Sales, Inc., and at what price?

Public shareholders may elect to redeem in connection with a combination vote and at each extension vote, at the pro-rata trust value on the relevant record date. Redemption is a right attached to the public shares only; warrants and rights carry no claim on the trust. The mechanics and the deadline for electing are set out in the proxy statement for the vote in question.

Is the trust value the same as the share price for Stem Sales, Inc.?

No. Trust per share is a disclosed, contractual figure: what a redeeming holder receives. The market price is whatever the shares change hands at, which can sit above the trust when a deal is well received or below it when the market doubts one will close. We do not have a current quote for this vehicle, so no spread is shown.

Who sponsors Stem Sales, Inc., and what is their track record?

Stem Sales is the sponsor entity, part of the Stem Sales franchise. This is the only vehicle we have attributed to that sponsor.

Is Stem Sales, Inc. a good investment?

That is not a question this site answers. Stem Sales, Inc. is covered here as reference data: what the company filed, when it filed it, and what the numbers in those filings say. The Edge, FOMO and Potential scores on this page are derived measures with a published formula, not ratings of investment merit: they describe the setup, and every component is shown so you can take them apart. We publish no price targets and no recommendations, and nothing here should be read as advice. The figures are a starting point for your own work, and each one carries the accession number of the filing it came from.

Where does this Stem Sales, Inc. data come from?

Filings Stem Sales, Inc. submitted to the SEC under CIK 0001614083: the registration statement and final prospectus for the structure, quarterly and annual reports for the trust, current reports and proxy statements for deals, votes and extensions. Trust economics are taken from the registrant's own XBRL tags rather than parsed from prose, which is why they are exact. Every filing in the history above is listed with its accession number, which identifies the document uniquely on EDGAR; Pro accounts open it directly from the row.

Compiled by the SPACListing research desk

Last reconciled Sep 4, 2026

Every figure on this page is read from documents the registrants filed with the U.S. Securities and Exchange Commission, principally the IPO prospectus (Form 424B4), quarterly and annual reports, current reports and proxy statements, the registrant's own XBRL tags for trust economics. Nothing is sourced from press coverage, from the companies themselves, or from a third-party aggregator. Where a filing does not disclose something, the field is left blank rather than estimated.

Read the full methodology · What is in the dataset · Report a correction

SPACListing is a reference-data service, not an investment adviser. Nothing here is a recommendation to buy or sell any security.

Continue reading

The context around this vehicle: who else the sponsor has launched, which banks priced it, and where it sits in the wider market.